Recent breast cancer studies have highlighted the important role that NF1 dysregulation has in both NF1-related and sporadic breast cancers with the focus being on epithelial cells (Zheng et al., 2020; Tovar et al., 2022). The gene discussed is NF1; the disease is breast cancer.